.
WuXi Biologics has been included in the “20 Case Examples for 20 Years: Private Sector’s Sustainable Development in China” report initiated by the United Nations Global Compact. This recognition highlights the company’s effective and dedicated efforts to continue the advancement of green biologics solutions for a healthier future.
The report, which aims to showcase best practices in ESG, features WuXi Biologics as a leading global CRDMO that is committed to pursuing sustainable development. The company’s business model and firm commitment to sustainability have earned it a spot in the report, which will be shared with the world through the UNGC global roadshow.
Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, expressed his honor at being included in the report and highlighted the company’s dedication to delivering ESG excellence. He also emphasized the company’s role as a global leader in Green CRDMO, providing end-to-end green biologics solutions driven by innovation.
WuXi Biologics’ inclusion in the report showcases its distinctive business model and commitment to sustainability. As a global leader in Green CRDMO, the company is dedicated to enabling global partners with end-to-end green biologics solutions, from green research and development to green manufacturing. This recognition further solidifies the company’s position as a leader in the industry and its commitment to promoting responsible practices for a healthier future.